<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="159825">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01994694</url>
  </required_header>
  <id_info>
    <org_study_id>riskperception.ctil</org_study_id>
    <nct_id>NCT01994694</nct_id>
  </id_info>
  <brief_title>Risk Perception in Adults With Attention Deficit and Hyperactivity Disorder (ADHD)</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shaare Zedek Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shaare Zedek Medical Center</source>
  <oversight_info>
    <authority>Israel: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      People with ADHD often engage in risky behaviors, such as dangerous driving, substance abuse
      and gambling. Current behavioral economy theories differentiate between risk perception and
      risk attitude. This study aims to measure both risk taking and risk perception in adults
      with and without ADHD. It is hypothesized that people with ADHD show decreased risk
      perception, accounting for their risky behavior. In contrast, it is hypothesized that people
      with ADHD do not show increased risk attitude, namely, they are not risk seeking.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">January 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Domain-specific Risk-Taking questionnaire</measure>
    <time_frame>1 day</time_frame>
    <safety_issue>No</safety_issue>
    <description>Subjects are given the questionnaire once</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">60</enrollment>
  <condition>ADHD</condition>
  <arm_group>
    <arm_group_label>adults with ADHD</arm_group_label>
    <description>adults with ADHD, without neurological and psychiatric comorbidities</description>
  </arm_group>
  <arm_group>
    <arm_group_label>controls</arm_group_label>
    <description>people without ADHD, with no neurological and psychiatric disorders</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adults with ADHD
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  clinical diagnosis of ADHD

        Exclusion Criteria:

          -  any neurological disorder

          -  any psychiatric disorder
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rachel Shoham, MA</last_name>
    <phone>972-54-6897393</phone>
    <email>rachelishoham@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Shaare Zedek Medical Center</name>
      <address>
        <city>Jerusalem</city>
        <zip>91031</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rachel Shoham, MA</last_name>
      <phone>972-54-6897393</phone>
      <email>rachelishoham@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>September 2013</verification_date>
  <lastchanged_date>November 24, 2013</lastchanged_date>
  <firstreceived_date>November 17, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Attention Deficit Disorder with Hyperactivity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
